Skip to main content
Premium Trial:

Request an Annual Quote

Paul Dark, Angela Caliendo, Stephan Harbarth, Romney Humphries

DNAe has appointed Paul Dark, Angela Caliendo, Stephan Harbarth, and Romney Humphries to its newly formed clinical advisory board. Dark serves as chair of critical care medicine at the University of Manchester. He also works as a national research lead in critical care for the National Institute of Health Research and as a visiting professor at King's College London. Caliendo serves as a professor, executive vice chair of the department of medicine, and a director of the division of general internal medicine at the Warren Alpert Medical School of Brown University. She also serves as editor for the Journal of Clinical Microbiology, chair of the Microbiology Medical Devices panel for the FDA, and serves on the board of directors of the Infectious Diseases Society of America. Harbarth serves as an associate professor at the University of Geneva and senior consultant at the Geneva University Hospitals. Humphries is an assistant professor in the department of pathology and laboratory medicine in the David Geffen School of Medicine at the University of California, Los Angeles.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.